Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  ERK inhibitor GDC-0994
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GO28885, NCI-2013-01262, 2013-000566-10, NCT01875705
Start Over